EM Vivas · Lower gastrointestinal bleed
Lower GI bleed — CTA localisation and embolisation viva
Clinical viva on unstable LGIB pathway, CTA interpretation, IR embolisation, and pitfalls.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
Priority diagnosis and CTA. Acute massive LGIB with right-colon active extravasation — severe LGIB → CTA localises and enables IR; do not delay embolisation for colonoscopy in the unstable patient.[1]
Therapy. Resuscitate with restrictive transfusion per local LGIB protocol; reverse anticoagulation per guideline; proceed to superselective embolisation (pooled technical success 97.0%, rebleed 20.7%, ischaemia 7.5%; post-2010 rebleed 18.6%, ischaemia 7.3%).[5] Failed embolisation → surgery. HDU/ICU.
Pitfalls. UGIB drugs; over-transfusion; attributing massive bleed to haemorrhoids; delaying IR for a "definitive colonoscopy diagnosis" — CTA-positive patients have a defined management role per guideline.[1]
References2ShowHide
- [1]Sengupta N, et al. Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline. American Journal of Gastroenterology, 2023.PMID 36735555
- [5]Yu Q, et al. Twenty years of embolization for acute lower gastrointestinal bleeding: a meta-analysis of rebleeding and ischaemia rates Br J Radiol, 2024.PMID 38364312